doi: 10.1001/jamadermatol.2022.5701.
Treatment of Trichilemmomas With Topical Sirolimus
Affiliations
- PMID: 36598777
- DOI: 10.1001/jamadermatol.2022.5701
Item in Clipboard
Treatment of Trichilemmomas With Topical Sirolimus
JAMA Dermatol.
.
No abstract available
Plain language summary
This case report describes a woman in her 60s flesh-colored papules that were localized to the central face and a lobular downgrowth of cells with clear, expanded, faintly glassy cytoplasm.
Similar articles
-
Topical sirolimus as an effective treatment for a deep neurofibroma in a patient with neurofibromatosis type I.Pediatr Dermatol. 2019 May;36(3):360-361. doi: 10.1111/pde.13782. Epub 2019 Mar 3. Pediatr Dermatol. 2019. PMID: 30828862
-
A novel immunosuppressive agent, sirolimus, in the treatment of Kaposi's sarcoma in a renal transplant recipient.Ren Fail. 2007;29(1):103-5. doi: 10.1080/08860220601039528. Ren Fail. 2007. PMID: 17365918
-
Sirolimus-associated regression of benign lymphangioendothelioma.J Am Acad Dermatol. 2014 Nov;71(5):e221-2. doi: 10.1016/j.jaad.2014.07.054. Epub 2014 Oct 15. J Am Acad Dermatol. 2014. PMID: 25438003 No abstract available.
-
Keratosis pilaris rubra successfully treated with topical sirolimus: Report of a case and review of the literature.Pediatr Dermatol. 2022 May;39(3):429-431. doi: 10.1111/pde.14963. Epub 2022 Mar 1. Pediatr Dermatol. 2022. PMID: 35229903 Free PMC article. Review.
-
Topical rapamycin (sirolimus) for the treatment of uncomplicated tufted angiomas in two children and review of the literature.Pediatr Dermatol. 2018 Sep;35(5):e286-e290. doi: 10.1111/pde.13596. Epub 2018 Jul 17. Pediatr Dermatol. 2018. PMID: 30015406 Review.
Cited by
-
Minimally Invasive Plasma Device Management of Multiple Benign Skin Cancers Associated with Rare Genodermatoses-Case Series and Review of the Therapeutic Methods.J Clin Med. 2024 Jul 26;13(15):4377. doi: 10.3390/jcm13154377. J Clin Med. 2024. PMID: 39124644 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
